Cargando…
ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231
BACKGROUND: Platinum-based drugs are used extensively in neoadjuvant chemotherapy for triple-negative breast cancer (TNBC), but their use can be limited by resistance. In this study, we established cisplatin (DDP) resistant TNBC cells to investigate the potential relationship among ETS1, IKKα/NF-κB...
Autores principales: | Zhang, Yuzhu, Wu, Jingjing, Ye, Meina, Wang, Bing, Sheng, Jiayu, Shi, Bailing, Chen, Hongfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009945/ https://www.ncbi.nlm.nih.gov/pubmed/29950928 http://dx.doi.org/10.1186/s12935-018-0581-4 |
Ejemplares similares
-
Neuropeptide-induced modulation of carcinogenesis in a metastatic breast cancer cell line (MDA-MB-231(LUC+))
por: Gutierrez, Silvia, et al.
Publicado: (2018) -
C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells
por: Jiang, Liangqian, et al.
Publicado: (2018) -
Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism
por: Hastings, Jordan, et al.
Publicado: (2017) -
Human cytomegalovirus interleukin-10 enhances matrigel invasion of MDA-MB-231 breast cancer cells
por: Valle Oseguera, Cendy A., et al.
Publicado: (2017) -
Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line
por: Wang, Ling, et al.
Publicado: (2013)